StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Marketing Plan

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Mar 03, 2021 1:25pm

121 Views

Post# 32706100

RE:RE:Marketing Plan

Nice try. Tripp has done an amazing job with turning this company around and pivoting with Covid the exception of expanding the brand awareness and marketing the company.

He needs help in this area and should acknoweldge that and either hire an internal marketing manager or an external PR firm. The only shortfall I have seen in the execution is getting the word out.

The reason I keep harping on this is with Aristotle coming it is even more critical to focus on marketing. We are less than 4 weeks away and still not a peep. you cant go from 0-100 mph in one NR.